CCTA plays two distinct roles in the CABG pathway: pre-operative surgical planning and post-operative graft evaluation. Grafts are large-caliber, relatively motion-resistant, and less prone to heavy calcification than native coronaries — making them comparatively easy to image. On 64-slice scanners CCTA achieves 100% sensitivity and 100% negative predictive value for graft occlusion or significant (> 50%) stenosis.
1 Appropriate use & clinical role
Under standard Appropriate Use Criteria, CCTA is appropriate for symptomatic patients after CABG (e.g., recurrent angina) but not appropriate for routine screening of asymptomatic patients, regardless of time since surgery.
Pre-CABG planning. The ACR Appropriateness Criteria recognize CCTA as complementary to invasive coronary angiography (ICA) for CABG planning. Specific strengths include:
- Hemodynamic significance of a lesion via CT-FFR.
- Visualization of coronary calcification to identify suitable bypass targets.
- Assessment of runoff distal to the graft target.
- Anomalous coronary origins — CCTA receives a Class 1 recommendation for preoperative evaluation, excelling at identifying high-risk features (acute angle of origin, proximal narrowing, slit-like elliptical cross-section suggesting an intramural course).
In known left main or 3-vessel disease, the SYNTAX III REVOLUTION RCT (223 patients) showed heart-team decisions based on CCTA had 92.8% agreement with decisions from ICA. The FASTTRACK CABG trial is evaluating complete planning and execution of CABG solely from CCTA with CT-FFR, without ICA.
Redo-CABG. CCTA is especially valuable before repeat surgery — detailing native coronaries and existing grafts (patency, location, stenosis). In an RCT of 688 patients with prior CABG, performing CCTA before ICA reduced ICA procedure time, contrast-associated nephropathy, and procedural complications; improved patient satisfaction; and reduced 1-year major adverse cardiac events.
Post-CABG chest pain. The 2021 AHA/ACC Chest Pain Guidelines give a Class 2a recommendation for stress imaging or CCTA to evaluate for ischemia or graft stenosis/occlusion in symptomatic post-CABG patients.
2 Types of bypass conduit
- Arterial grafts
- Left Internal Mammary Artery (LIMA) — the workhorse conduit, typically to the LAD
- Right Internal Mammary Artery (RIMA)
- Radial artery segments
- Venous grafts
- Autologous reversed saphenous vein grafts (SVG)
3 Protocol & imaging techniques
- Extend the scan range superiorly. In a post-CABG patient the scan must reach high enough to include the LIMA takeoff from the subclavian artery — so a proximal subclavian stenosis or LIMA ostial stenosis, either of which can impair graft function or cause a coronary-subclavian “steal,” is not missed.
- 3D volume rendering maps complex graft anatomy, showing the spatial relationship between grafts, native coronaries, sternum, and aortic anastomoses — valuable for planning future catheterization or redo sternotomy.
4 Diagnostic accuracy
In a study of 399 patients, CCTA achieved 96.5% sensitivity, 96.5% specificity, and 99.0% negative predictive value for selecting CABG candidates per ACCF/AHA guidelines, comparable to ICA; adding a CT-based SYNTAX score raised specificity to 98.3%.
For post-CABG graft evaluation, CCTA has excellent accuracy for detecting complete graft occlusion (99% sensitivity and 99% specificity), with successful graft evaluation in 93–100% of patients. It is less robust for assessing native coronary vessels in post-CABG patients, owing to a high proportion of non-diagnostic segments.
Emerging photon-counting detector CT shows promise for improving assessment of heavily calcified coronary lesions — a traditional limitation of conventional CCTA.
5 Evaluating graft failure
Graft failure is common — particularly in SVGs, which carry a cumulative failure rate of ~50% at 10 years. Failure occurs in distinct phases:
| Phase | Time post-op | Approx. failure rate | Mechanism |
|---|---|---|---|
| Acute | < 1 month | ~10% | Acute thrombosis or technical factors |
| Subacute | 1–12 months | ~15% | Neointimal hyperplasia (intimal thickening) |
| Late | > 1 year | ~25% | Accelerated atherosclerosis within the graft |
Graft disease tends to manifest as complete occlusion more often than nonocclusive stenosis.
CT findings of occlusion:
- Absence of luminal contrast, with the graft filled by low-density material (thrombus).
- At the aortic anastomosis, an occluded vein graft often leaves a characteristic “button” — a small, smooth contrast outpouching off the aortic root.
6 Imaging challenges & artifacts
Native (non-grafted / run-off) vessels in post-CABG patients are typically advanced in disease, heavily calcified, and small in caliber — making them notably less accurate to assess than the grafts themselves.
Metallic clips — especially those placed alongside the LIMA to ligate side branches — produce beam-hardening and streak artifact that can obscure the adjacent graft lumen.
Because grafts do not lie directly on the beating heart surface, they experience less cardiac motion than native coronaries and calcify less heavily — making them comparatively easier to evaluate, including for soft plaque.
7 Complications — Saphenous Vein Graft Aneurysm (SVGA)
A late complication of CABG is saphenous vein graft aneurysm, driven by accelerated atherosclerosis.
- Can grow large — averaging ~6 cm, with reported cases > 15 cm.
- Often discovered incidentally as a rounded anterior mediastinal mass on chest radiography.
- ECG-gated CCTA is the best tool to characterize SVGAs, distinguishing the aneurysmal dilation and identifying associated mural thrombus.
8 Key limitations
- Heavy coronary calcification can limit luminal assessment of native vessels; photon-counting CT may mitigate this.
- Native-vessel evaluation in post-CABG patients has higher rates of non-diagnostic segments.
- Positive predictive value for perioperative MACE is low — CCTA may overestimate risk in the preoperative setting.
Clinical bottom line. CCTA is a strong complementary tool across the entire CABG pathway: it informs surgical planning (target identification, runoff, anomalous origins, CT-FFR), streamlines redo-CABG and post-CABG ICA, and provides excellent rule-out of graft occlusion in symptomatic patients. Its main weaknesses are native-vessel assessment in heavily calcified coronaries and a low PPV for perioperative MACE.
References
- Expert Panel on Cardiac Imaging, Malik SB, Moore WH, et al. ACR Appropriateness Criteria® Preprocedural Chest or Cardiac Imaging for Cardiothoracic Surgery. J Am Coll Radiol. 2026;S1546-1440(26)00059-1. doi:10.1016/j.jacr.2026.01.031
- Andreini D, Collet C, Leipsic J, et al. Pre-Procedural Planning of Coronary Revascularization by Cardiac Computed Tomography: An Expert Consensus Document of the SCCT. J Cardiovasc Comput Tomogr. 2022;16(6):558–572. PubMed
- Serruys PW, Hara H, Garg S, et al. Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(7):713–736. PubMed
- Suh YJ, Hong YJ, Lee HJ, et al. Accuracy of CT for Selecting Candidates for Coronary Artery Bypass Graft Surgery: Combination With the SYNTAX Score. Radiology. 2015;276(2):390–9. PubMed
- Kotronias RA, de Maria GL, Xie C, et al. Benchmarking Photon-Counting CT Angiography Against Invasive Assessment of Coronary Stenosis: Implications for Severely Calcified Coronaries. JACC Cardiovasc Imaging. 2025;18(5):572–585. PubMed
- Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain. J Am Coll Cardiol. 2021;78(22):e187–e285. doi:10.1016/j.jacc.2021.07.053
- Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA 2010 Appropriate Use Criteria for Cardiac CT. J Am Coll Cardiol. 2010;56(22):1864–94. PubMed
- Writing Committee Members, Thompson A, Fleischmann KE, et al. 2024 AHA/ACC Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. J Am Coll Cardiol. 2024;84(19):1869–1969. PubMed